Ryan Allway October 12th, 2021 Psychedelics, Top News MIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research organization (CRO) that is... Read more
Ketamine One Subsidiary KGK Science Contracted to Support a Ketamine Clinical Trial in the United States
October 6, 2021
VANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that its wholly-owned contract research organization,... Read more
Next Green Wave Eliminates All Debt
October 6, 2021
Ryan Allway October 6th, 2021 News, Top News Vancouver, British Columbia–(Newsfile Corp. – October 6, 2021) – Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”), a premium seed-to-shelf craft cannabis producer, is pleased to announce the following financial updates: Loan Fully Repaid As... Read more
MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. The focus of this study will be on the... Read more
Cannabix Technologies Ramps Up Beta Testing with THC Breathalyzer and Ships Additional Devices
September 27, 2021
For immediate release. Vancouver, British Columbia, September 27, 2021: Cannabix Technologies Inc.(CSE: BLO, OTC PINK CURRENT: BLOZF) (the “Company”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace reports that it is ramping up subject beta testing in a high-volume clinic in the Northwestern US and will... Read more
Decibel Announces 27 New Upcoming Ontario Product Launches
September 22, 2021
Ryan Allway September 22nd, 2021 News, Top News CALGARY, AB, Sept. 22, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce its recent success in the Ontario product call as well as upcoming Ontario product launches with 27 new product introductions over... Read more
Poda to Attend 2021 Global Tobacco and Nicotine Forum
September 20, 2021
Ryan Allway September 20th, 2021 News, Top News VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ – PODA LIFESTYLE AND WELLNESS LTD. (“Poda” or the “Company”) (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that its CEO, Mr. Ryan Selby, and Mr. Nicholas Kadysh, member of Poda’s Strategic Advisory Board, will be attending the Global... Read more
Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
September 17, 2021
Ryan Allway September 17th, 2021 Psychedelics, Top News Enveric intends to immediately accelerate the development of a novel Psychedelic molecule for Cancer Related Distress NAPLES, Fla., Sept. 17, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer... Read more
Decibel Closes Previously Announced Offering of Units for Total Gross Proceeds of Approximately $15 Million, including Full Exercise of Over-Allotment Option
September 16, 2021
Ryan Allway September 16th, 2021 News, Top News CALGARY, AB, Sept. 16, 2021 /CNW/ – Decibel Cannabis Company Inc. (“Decibel” or the “Company“) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the closing of its previously announced bought deal prospectus offering (the “Offering“) of units of the Company (“Units“).... Read more
Enveric & MagicMed: Combining Drug Discovery with Clinical Expertise
September 9, 2021
Ryan Allway September 9th, 2021 Psychedelics, Top News Enveric Biosciences Inc.’s (NASDAQ: ENVB) focus has been on discovering and developing cannabinoid-based therapeutics for patients suffering from the side effects of cancer treatments. With the acquisition of MagicMed Industries, the company also sees an opportunity in cancer-related distress from anxiety,... Read more
